ESPR vs HIVE

Comparison between Esperion Therapeutics Inc (ESPR, Company) and HIVE Digital Technologies Ltd (HIVE, Company).

ESPR is from the Healthcare sector, while HIVE is from the Financial Services sector.

5-Year PerformanceHIVE has outperformed ESPR, delivering a return of -21.2% compared to -33.8%

ESPR vs HIVE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ESPR(COMPANY)	HIVE(COMPANY)
Market Cap	$789M	$789M
Max Drawdown	99.37%	97.73%
Sharpe Ratio	1.41	1.08
5Y Beta	1.35	2.70
Industry	Drug Manufacturers - Specialty & Generic	Capital Markets
P/E Ratio	-5.96	-5.31
Forward P/E	4.64	62.89
PEG Ratio	-0.74	-0.00
5Y EPS CAGR	-31.57%	N/A
Debt to Equity	0.00%	0.38%
Free Cash Flow Yield	-2.33%	7.90%
P/S Ratio	1.94	3.80
P/B Ratio	98.42	1.77

Market Cap

Winner

ESPR

$789M

HIVE

$789M

Max Drawdown

ESPR

99.37%

Winner

HIVE

97.73%

Sharpe Ratio

Winner

ESPR

1.41

HIVE

1.08

5Y Beta

Winner

ESPR

1.35

HIVE

2.70

Industry

ESPR

Drug Manufacturers - Specialty & Generic

HIVE

Capital Markets

P/E Ratio

Winner

ESPR

-5.96

HIVE

-5.31

Forward P/E

Winner

ESPR

4.64

HIVE

62.89

PEG Ratio

Winner

ESPR

-0.74

HIVE

-0.00

5Y EPS CAGR

ESPR

-31.57%

HIVE

N/A

Debt to Equity

Winner

ESPR

0.00%

HIVE

0.38%

Free Cash Flow Yield

ESPR

-2.33%

Winner

HIVE

7.90%

P/S Ratio

Winner

ESPR

1.94

HIVE

3.80

P/B Ratio

ESPR

98.42

Winner

HIVE

1.77

ESPR vs HIVE - Historical Returns

Returns include dividend reinvestment.

Period	ESPR	HIVE
1 month	+0.96%	+47.21%
3 months	+17.10%	+80.00%
6 months	-16.67%	+42.45%
1 year	+169.23%	+108.42%
5 years(CAGR)	-33.82%	-21.16%
10 years(CAGR)	-15.63%	-13.32%
Max(CAGR)	-11.11%	-13.32%

ESPR

+0.96%

Winner

HIVE

+47.21%

ESPR

+17.10%

Winner

HIVE

+80.00%

ESPR

-16.67%

Winner

HIVE

+42.45%

Winner

ESPR

+169.23%

HIVE

+108.42%

5Y(CAGR)

ESPR

-33.82%

Winner

HIVE

-21.16%

10Y(CAGR)

ESPR

-15.63%

Winner

HIVE

-13.32%

Max(CAGR)

Winner

ESPR

-11.11%

HIVE

-13.32%

ESPR vs HIVE - Annual Returns (2013 - 2026)

Returns include dividend reinvestment.

Year	ESPR	HIVE
2026	-15.09%	+45.05%
2025	+68.18%	-16.50%
2024	-24.66%	-35.08%
2023	-48.80%	+196.08%
2022	+20.04%	-89.17%
2021	-81.96%	+35.38%
2020	-57.61%	+2600.00%
2019	+30.45%	-66.95%
2018	-30.83%	-92.61%
2017	+411.18%	N/A
2016	-42.17%	N/A
2015	-46.01%	N/A
2014	+191.35%	N/A
2013	-5.24%	N/A

ESPR vs HIVE Drawdown Comparison

The maximum drawdown for ESPR was -99.37%, occurring on May 14, 2025. This drawdown has not yet recovered.

The maximum drawdown for HIVE was -97.73%, occurring on Dec 17, 2019. Recovery took 752 trading sessions.

The current ESPR drawdown is -97.27%. The current HIVE drawdown is -85.24%.

Rank	ESPR	HIVE
#1	-99.37% May 19, 2015 - May 14, 2025	-97.73% Jan 12, 2018 - Jan 8, 2021
#2	-41.24% Oct 2, 2013 - Sep 26, 2014	-95.12% Feb 19, 2021 - Apr 8, 2025
#3	-28.66% Oct 8, 2014 - Oct 31, 2014	-32.45% Jan 8, 2021 - Feb 12, 2021
#4	-22.60% Mar 23, 2015 - May 19, 2015	N/A
#5	-18.82% Aug 5, 2013 - Sep 26, 2013	N/A
#6	-13.95% Oct 31, 2014 - Nov 12, 2014	N/A
#7	-12.84% Jan 14, 2015 - Feb 3, 2015	N/A
#8	-12.54% Dec 9, 2014 - Dec 31, 2014	N/A
#9	-12.35% Feb 18, 2015 - Mar 12, 2015	N/A
#10	-10.06% Nov 18, 2014 - Dec 4, 2014	N/A
#11	-6.74% Jan 12, 2015 - Jan 14, 2015	N/A
#12	-6.30% Jan 8, 2015 - Jan 12, 2015	N/A
#13	-3.45% Jun 26, 2013 - Jul 2, 2013	N/A
#14	-3.06% Jul 16, 2013 - Jul 29, 2013	N/A
#15	-2.87% Sep 26, 2014 - Sep 30, 2014	N/A